Global and United States Therapeutic Vaccines Market Insights, Forecast to 2026

Global and United States Therapeutic Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Therapeutic Vaccines Product Introduction
1.2 Market Segments
1.3 Key Therapeutic Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Therapeutic Vaccines Market Size Growth Rate by Type
1.4.2 Peptide Therapeutic Vaccine
1.4.3 Cell Therapeutic Vaccine
1.4.4 Nucleic Acid Therapeutic Vaccine
1.5 Market by Application
1.5.1 Global Therapeutic Vaccines Market Size Growth Rate by Application
1.5.2 Oncotherapy
1.5.3 Hepatitis B
1.5.4 Tuberculosis
1.5.5 Herpes Simplex Virus
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Therapeutic Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Therapeutic Vaccines Revenue 2015-2026
2.1.2 Global Therapeutic Vaccines Sales 2015-2026
2.2 Global Therapeutic Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Therapeutic Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Therapeutic Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Therapeutic Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Therapeutic Vaccines Revenue Forecast by Region (2021-2026)
3 Global Therapeutic Vaccines Competitor Landscape by Players
3.1 Global Top Therapeutic Vaccines Sales by Manufacturers
3.1.1 Global Therapeutic Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Therapeutic Vaccines Manufacturers by Revenue
3.2.1 Global Therapeutic Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Therapeutic Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Therapeutic Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Therapeutic Vaccines Revenue in 2019
3.2.5 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Therapeutic Vaccines Price by Manufacturers
3.4 Global Therapeutic Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Therapeutic Vaccines Market Size by Type (2015-2020)
4.1.1 Global Therapeutic Vaccines Sales by Type (2015-2020)
4.1.2 Global Therapeutic Vaccines Revenue by Type (2015-2020)
4.1.3 Therapeutic Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Therapeutic Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Therapeutic Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Therapeutic Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Therapeutic Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Therapeutic Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Therapeutic Vaccines Market Size by Application (2015-2020)
5.1.1 Global Therapeutic Vaccines Sales by Application (2015-2020)
5.1.2 Global Therapeutic Vaccines Revenue by Application (2015-2020)
5.1.3 Therapeutic Vaccines Price by Application (2015-2020)
5.2 Therapeutic Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Therapeutic Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Therapeutic Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Therapeutic Vaccines Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Therapeutic Vaccines Market Size YoY Growth 2015-2026
6.1.1 United States Therapeutic Vaccines Sales YoY Growth 2015-2026
6.1.2 United States Therapeutic Vaccines Revenue YoY Growth 2015-2026
6.1.3 United States Therapeutic Vaccines Market Share in Global Market 2015-2026
6.2 United States Therapeutic Vaccines Market Size by Players (International and Local Players)
6.2.1 United States Top Therapeutic Vaccines Players by Sales (2015-2020)
6.2.2 United States Top Therapeutic Vaccines Players by Revenue (2015-2020)
6.3 United States Therapeutic Vaccines Historic Market Review by Type (2015-2020)
6.3.1 United States Therapeutic Vaccines Sales Market Share by Type (2015-2020)
6.3.2 United States Therapeutic Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 United States Therapeutic Vaccines Price by Type (2015-2020)
6.4 United States Therapeutic Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Therapeutic Vaccines Sales Forecast by Type (2021-2026)
6.4.2 United States Therapeutic Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 United States Therapeutic Vaccines Price Forecast by Type (2021-2026)
6.5 United States Therapeutic Vaccines Historic Market Review by Application (2015-2020)
6.5.1 United States Therapeutic Vaccines Sales Market Share by Application (2015-2020)
6.5.2 United States Therapeutic Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 United States Therapeutic Vaccines Price by Application (2015-2020)
6.6 United States Therapeutic Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Therapeutic Vaccines Sales Forecast by Application (2021-2026)
6.6.2 United States Therapeutic Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 United States Therapeutic Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Therapeutic Vaccines Market Size YoY Growth 2015-2026
7.2 North America Therapeutic Vaccines Market Facts & Figures by Country
7.2.1 North America Therapeutic Vaccines Sales by Country (2015-2020)
7.2.2 North America Therapeutic Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Therapeutic Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Therapeutic Vaccines Market Facts & Figures by Country
8.2.1 Europe Therapeutic Vaccines Sales by Country
8.2.2 Europe Therapeutic Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Therapeutic Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Therapeutic Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Therapeutic Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Therapeutic Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Therapeutic Vaccines Market Facts & Figures by Country
10.2.1 Latin America Therapeutic Vaccines Sales by Country
10.2.2 Latin America Therapeutic Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Therapeutic Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Therapeutic Vaccines Sales by Country
11.2.2 Middle East and Africa Therapeutic Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Northeast Biotherapeutics
12.1.1 Northeast Biotherapeutics Corporation Information
12.1.2 Northeast Biotherapeutics Description and Business Overview
12.1.3 Northeast Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
12.1.5 Northeast Biotherapeutics Recent Development
12.2 Agenus
12.2.1 Agenus Corporation Information
12.2.2 Agenus Description and Business Overview
12.2.3 Agenus Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Agenus Therapeutic Vaccines Products Offered
12.2.5 Agenus Recent Development
12.3 Vaccinogen Inc
12.3.1 Vaccinogen Inc Corporation Information
12.3.2 Vaccinogen Inc Description and Business Overview
12.3.3 Vaccinogen Inc Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Vaccinogen Inc Therapeutic Vaccines Products Offered
12.3.5 Vaccinogen Inc Recent Development
12.4 CIMAB S.A
12.4.1 CIMAB S.A Corporation Information
12.4.2 CIMAB S.A Description and Business Overview
12.4.3 CIMAB S.A Sales, Revenue and Gross Margin (2015-2020)
12.4.4 CIMAB S.A Therapeutic Vaccines Products Offered
12.4.5 CIMAB S.A Recent Development
12.5 Dendreon
12.5.1 Dendreon Corporation Information
12.5.2 Dendreon Description and Business Overview
12.5.3 Dendreon Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dendreon Therapeutic Vaccines Products Offered
12.5.5 Dendreon Recent Development
12.6 Corixa
12.6.1 Corixa Corporation Information
12.6.2 Corixa Description and Business Overview
12.6.3 Corixa Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Corixa Therapeutic Vaccines Products Offered
12.6.5 Corixa Recent Development
12.7 AVAX Technologies
12.7.1 AVAX Technologies Corporation Information
12.7.2 AVAX Technologies Description and Business Overview
12.7.3 AVAX Technologies Sales, Revenue and Gross Margin (2015-2020)
12.7.4 AVAX Technologies Therapeutic Vaccines Products Offered
12.7.5 AVAX Technologies Recent Development
12.11 Northeast Biotherapeutics
12.11.1 Northeast Biotherapeutics Corporation Information
12.11.2 Northeast Biotherapeutics Description and Business Overview
12.11.3 Northeast Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
12.11.5 Northeast Biotherapeutics Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Therapeutic Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Therapeutic Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Therapeutic Vaccines Market Segments
Table 2. Ranking of Global Top Therapeutic Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Therapeutic Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Peptide Therapeutic Vaccine
Table 5. Major Manufacturers of Cell Therapeutic Vaccine
Table 6. Major Manufacturers of Nucleic Acid Therapeutic Vaccine
Table 7. Global Therapeutic Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Therapeutic Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Therapeutic Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global Therapeutic Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Therapeutic Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Therapeutic Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Therapeutic Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Therapeutic Vaccines Sales Share by Manufacturers (2015-2020)
Table 15. Global Therapeutic Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Therapeutic Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Vaccines as of 2019)
Table 17. Therapeutic Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Therapeutic Vaccines Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Therapeutic Vaccines Price (2015-2020) (USD/Unit)
Table 20. Therapeutic Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Therapeutic Vaccines Product Type
Table 22. Date of International Manufacturers Enter into Therapeutic Vaccines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 25. Global Therapeutic Vaccines Sales Share by Type (2015-2020)
Table 26. Global Therapeutic Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Therapeutic Vaccines Revenue Share by Type (2015-2020)
Table 28. Therapeutic Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Therapeutic Vaccines Sales Share by Type (2021-2026)
Table 30. Global Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 31. Global Therapeutic Vaccines Sales Share by Application (2015-2020)
Table 32. Global Therapeutic Vaccines Sales Share by Application (2021-2026)
Table 33. Global Therapeutic Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Therapeutic Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Therapeutic Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Therapeutic Vaccines Sales (K Units) of Key Companies (2015-2020)
Table 37. United States Therapeutic Vaccines Sales Share by Company (2015-2020)
Table 38. United States Therapeutic Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Therapeutic Vaccines Sales (K Units) by Type (2015-2020)
Table 40. United States Therapeutic Vaccines Sales Share by Type (2015-2020)
Table 41. United States Therapeutic Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Therapeutic Vaccines Price (K Units) by Type (2015-2020)
Table 43. United States Therapeutic Vaccines Sales (K Units) by Type (2021-2026)
Table 44. United States Therapeutic Vaccines Sales Share by Type (2021-2026)
Table 45. United States Therapeutic Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Therapeutic Vaccines Revenue Share by Type (2021-2026)
Table 47. United States Therapeutic Vaccines Price (K Units) by Type (2021-2026)
Table 48. United States Therapeutic Vaccines Sales (K Units) by Application (2015-2020)
Table 49. United States Therapeutic Vaccines Sales Share by Application (2015-2020)
Table 50. United States Therapeutic Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Therapeutic Vaccines Sales (K Units) by Application (2021-2026)
Table 52. United States Therapeutic Vaccines Sales Share by Application (2021-2026)
Table 53. United States Therapeutic Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Therapeutic Vaccines Revenue Share by Application (2021-2026)
Table 55. North America Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 56. North America Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 57. North America Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 59. Europe Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 60. Europe Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 61. Europe Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Therapeutic Vaccines Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Therapeutic Vaccines Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Therapeutic Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Therapeutic Vaccines Revenue Market Share by Region (2015-2020)
Table 67. Latin America Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 68. Latin America Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 75. Northeast Biotherapeutics Corporation Information
Table 76. Northeast Biotherapeutics Description and Business Overview
Table 77. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Northeast Biotherapeutics Therapeutic Vaccines Product
Table 79. Northeast Biotherapeutics Recent Development
Table 80. Agenus Corporation Information
Table 81. Agenus Description and Business Overview
Table 82. Agenus Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Agenus Product
Table 84. Agenus Recent Development
Table 85. Vaccinogen Inc Corporation Information
Table 86. Vaccinogen Inc Description and Business Overview
Table 87. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Vaccinogen Inc Product
Table 89. Vaccinogen Inc Recent Development
Table 90. CIMAB S.A Corporation Information
Table 91. CIMAB S.A Description and Business Overview
Table 92. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. CIMAB S.A Product
Table 94. CIMAB S.A Recent Development
Table 95. Dendreon Corporation Information
Table 96. Dendreon Description and Business Overview
Table 97. Dendreon Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Dendreon Product
Table 99. Dendreon Recent Development
Table 100. Corixa Corporation Information
Table 101. Corixa Description and Business Overview
Table 102. Corixa Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Corixa Product
Table 104. Corixa Recent Development
Table 105. AVAX Technologies Corporation Information
Table 106. AVAX Technologies Description and Business Overview
Table 107. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. AVAX Technologies Product
Table 109. AVAX Technologies Recent Development
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Therapeutic Vaccines Players
Table 114. Therapeutic Vaccines Customers List
Table 115. Therapeutic Vaccines Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Vaccines Product Picture
Figure 2. Global Therapeutic Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Peptide Therapeutic Vaccine Product Picture
Figure 4. Cell Therapeutic Vaccine Product Picture
Figure 5. Nucleic Acid Therapeutic Vaccine Product Picture
Figure 6. Global Therapeutic Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Oncotherapy
Figure 8. Hepatitis B
Figure 9. Tuberculosis
Figure 10. Herpes Simplex Virus
Figure 11. Others
Figure 12. Therapeutic Vaccines Report Years Considered
Figure 13. Global Therapeutic Vaccines Market Size 2015-2026 (US$ Million)
Figure 14. Global Therapeutic Vaccines Sales 2015-2026 (K Units)
Figure 15. Global Therapeutic Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Therapeutic Vaccines Sales Market Share by Region (2015-2020)
Figure 17. Global Therapeutic Vaccines Sales Market Share by Region in 2019
Figure 18. Global Therapeutic Vaccines Revenue Market Share by Region (2015-2020)
Figure 19. Global Therapeutic Vaccines Revenue Market Share by Region in 2019
Figure 20. Global Therapeutic Vaccines Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Therapeutic Vaccines Revenue in 2019
Figure 22. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Therapeutic Vaccines Sales Market Share by Type (2015-2020)
Figure 24. Global Therapeutic Vaccines Sales Market Share by Type in 2019
Figure 25. Global Therapeutic Vaccines Revenue Market Share by Type (2015-2020)
Figure 26. Global Therapeutic Vaccines Revenue Market Share by Type in 2019
Figure 27. Global Therapeutic Vaccines Market Share by Price Range (2015-2020)
Figure 28. Global Therapeutic Vaccines Sales Market Share by Application (2015-2020)
Figure 29. Global Therapeutic Vaccines Sales Market Share by Application in 2019
Figure 30. Global Therapeutic Vaccines Revenue Market Share by Application (2015-2020)
Figure 31. Global Therapeutic Vaccines Revenue Market Share by Application in 2019
Figure 32. United States Therapeutic Vaccines Sales Growth Rate 2015-2026 (K Units)
Figure 33. United States Therapeutic Vaccines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. United States Therapeutic Vaccines Market Share in Global Market 2015-2026
Figure 35. United States 5 and 10 Largest Therapeutic Vaccines Players Market Share by Revenue in Therapeutic Vaccines in 2019
Figure 36. United States Therapeutic Vaccines Revenue Share by Type (2015-2020)
Figure 37. United States Therapeutic Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 38. United States Therapeutic Vaccines Revenue Share by Application (2015-2020)
Figure 39. United States Therapeutic Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 41. North America Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 43. North America Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 44. U.S. Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. U.S. Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. Canada Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 49. Europe Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 51. Europe Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 52. Germany Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Germany Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. France Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 57. U.K. Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. Italy Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Russia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 63. Asia Pacific Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Therapeutic Vaccines Sales Market Share by Region in 2019
Figure 65. Asia Pacific Therapeutic Vaccines Revenue Market Share by Region in 2019
Figure 66. China Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. China Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Japan Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. South Korea Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. India Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Australia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Taiwan Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Indonesia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Thailand Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 83. Malaysia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 85. Philippines Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 87. Vietnam Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 91. Latin America Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 92. Mexico Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Middle East and Africa Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 102. Turkey Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Porter's Five Forces Analysis
Figure 109. Therapeutic Vaccines Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs